Visit Twellow.com

Generic

Social Networks And Brand Advertising Syndicate content

U.S. social networking sites may generate revenue that could reach $1 billion in 2007, and increase from $400 million in 2006, according to IDC's "Social Networking Services in the US-Popular, Yes, But how To Monetize Them?" report.

Google Losing Fight For Its Name Syndicate content

The search advertising company has been fighting against the usage of its name as a verb ever since Merriam-Webster put 'google' in the dictionary. It's a battle they are not going to win.

Does Google Police Online Pharmacies Enough? Syndicate content

Recent deaths associated with drugs bought at online pharmacies have brought the issue front and center for many Americans. It's still unclear as to whose responsibility it is to police them, but the strongest critics are pointing fingers at search engines and comparison-shopping sites.

Will Domain Names Become Less Relevant? Syndicate content

Currently domain names carry significant weight in Google's relevancy algorithms if they match the search query, but that is a signal destined to lose value.

Fake Generic Viagra Site Using Google Name Syndicate content

The Register writes about a fake pharmacy, which purports to sell pills that don't exist, and uses the Google name to try to appear legitimate.

Why Experts Reject Generic Memetrackers Syndicate content

Last week Scoble explained why he was unsubscribing from Memeorandum. More recently he wrote...
News Tags: Generic, Memetrackers

Why Experts are Rejecting Generic Memetrackers Syndicate content

Last week Scoble explained why he was unsubscribing from Memeorandum.
News Tags: WAS, Memetrackers, Generic

Teva/Ranbaxy Required To Withdraw Generic Quinapril Syndicate content

Pfizer has obtained a preliminary injunction halting sales of a generic quinapril product marketed by Teva Pharmaceuticals USA, Ranbaxy Pharmaceuticals, and Ranbaxy Laboratories.
News Tags: Generic

Novartis Buys Up Generic Drug Makers Syndicate content

Novartis is buying generic-drug makers Eon Labs and Hexal for a total of $8.3 billion in cash.
News Tags: Generic

Novartis Buys 2 Big Generic Drug Companies Syndicate content

Novartis is acquiring two leading generic drug companies that will be integrated into the company's Sandoz division.
News Tags: Generic